| 前收市價 | 3.1500 |
| 開市 | 3.1800 |
| 買盤 | 3.1500 x 400 |
| 賣出價 | 3.2200 x 400 |
| 今日波幅 | 3.1200 - 3.2280 |
| 52 週波幅 | 2.9800 - 13.8500 |
| 成交量 | |
| 平均成交量 | 131,117 |
| 市值 | 134.983M |
| Beta 值 (5 年，每月) | 0.56 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -2.2300 |
| 業績公佈日 | 2024年2月26日 - 2024年3月01日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 15.33 |
ZacksRepare Therapeutics Inc. (RPTX) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
Repare Therapeutics Inc. (RPTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksRepare Therapeutics Inc. (RPTX) Soars 8.8%: Is Further Upside Left in the Stock?
Repare Therapeutics Inc. (RPTX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
ZacksBiogen (BIIB) to Stop Selling Alzheimer's Disease Drug Aduhelm
Biogen (BIIB) aims to build a leading Alzheimer's disease franchise with the new drug Leqembi. The company quits commercializing the controversial Alzheimer's disease drug, Aduhelm.
